Florida Gov. Ron DeSantis has been criticized for efforts to ban mask mandates and vaccine passports.
Meanwhile, he's touting a COVID-19 antibody treatment in which a top donor’s company has invested millions of dollars.
DeSantis has been promoting the effectiveness of Regeneron, a monoclonal antibody treatment.
Filings with the U.S. Securities and Exchange Commission show Citadel, a Chicago-based hedge fund, has $15.9 million in shares of Regeneron Pharmaceuticals as well as options to buy its stock.
Citadel CEO Ken Griffin has donated $10.75 million to a political committee that supports DeSantis.
Citadel’s investment in Regeneron is a tiny fraction of its overall $39 billion in investments. Experts say Regeneron is an effective treatment.
